Sort
48,018 grants matching “immunotherapy”
The Boston Lung Cancer Survival Cohort
$1,231,212David C Christiani · Harvard School Of Public Health · U01 · FY2023 · CA
A Sparse-readout Quantitative PET scanner for breast cancer therapy optimization
$1,231,107William Coulis Jason Hunter · Pet/X, Llc · R42 · FY2020 · CA
The Atlantic Coast Sexually Transmitted Infection Cooperative Research Center (AC
$1,230,985Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2014 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Final preclinical development of an immunoadhesin therapy for inhalation anthrax
$1,230,830Keith Wycoff · Planet Biotechnology, Inc. · R01 · FY2012 · AI
NYU Melanoma SPORE
$1,230,080Iman Osman · New York University School Of Medicine · P50 · FY2025 · CA
DF/HCC Kidney Cancer SPORE (supplement)
$1,230,080David McDermott · Beth Israel Deaconess Medical Center · P50 · FY2025 · CA
DIABETES PREVENTION TRIAL-IDDM (DPT-1)
$1,229,837Joslin Diabetes Center · U01 · FY2000 · DK
Development of CM-HZ01 as a non-alpha-IL2 therapeutic for the treatment of metastatic melanoma
$1,228,902Colleen Doyle Cooper · Celdara Medical, Llc · R44 · FY2025 · CA
The cBioPortal for Cancer Genomics
$1,228,423Nikolaus Schultz · Sloan-Kettering Inst Can Research · U24 · FY2019 · CA
Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models
$1,228,372Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
PSMA-TARGETED ACTIVATED MYELOID CELLS AS A NOVEL PROSTATE CANCER IMMUNOTHERAPY.
$1,228,125The Johns Hopkins University · · FY2021 · Department of the Army
ADULT AIDS CLINICAL TRIALS UNIT
$1,227,954University Of Pittsburgh At Pittsburgh · U01 · FY2001 · AI
Multi-OMICS identification and validation of mechanisms triggered by Immune interventions aimed at reducing the size of the replication competent Reservoir
$1,227,889Rafick-Pierre Sekaly · Emory University · P01 · FY2025 · AI
Therapeutic Vaccine Targeting CMV Antigens in Glioblastoma
$1,227,385John H Sampson · Annias Immunotherapeutics, Inc. · R42 · FY2015 · CA
The connection of innate and adaptive anti-cancer immunity
$1,227,316John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Cancer Prevention by Vaccination against Induced Antigens
$1,227,167Powel Brown · University Of Tx Md Anderson Can Ctr · N01 · FY2019 · CA
Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,227,024Robert Simpson · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Pathogenesis and countermeasures of poxviruses and hemorrhagic fever viruses
$1,226,752Peter Jahrling · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Seattle-Lausanne Clinical Trials Unit
$1,226,577Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2022 · AI
Immunology of aging and immunotherapy of aging-associated diseases
$1,226,456Arya Biragyn · National Institute On Aging · ZIA · FY2022 · AG
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
$1,226,238Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Effects of systemic and topical perturbations on human microbes
$1,225,978Heidi Kong · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Protein Expression Facility
$1,225,897Robert Petrovich · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES